Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers
Clinical trial NCT03798626 · COMPLETED
Trial details
- NCT number
- NCT03798626
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-22
- Primary completion
- 2023-03-01
- Enrollment
- 167
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.